|
|
|
|
|
Legal status
Patent not validated
| (51) | INT.CL. | A61K 39/00 | |
| A61K 39/395 | |||
| A61P 27/00 | |||
| C07K 14/00 | |||
| C07K 16/28 |
| (11) | Number of the document | 2943218 |
| (13) | Kind of document | T |
| (96) | European patent application number | 14701449.2 |
| Date of filing the European patent application | 2014-01-07 | |
| (97) | Date of publication of the European application | 2015-11-18 |
| (45) | Date of publication and mention of the grant of the patent | 2018-08-08 |
| (46) | Date of publication of the claims translation |
| (86) | Number | PCT/US2014/010395 |
| Date | 2014-01-07 |
| (87) | Number | WO 2014/109999 |
| Date | 2014-07-17 |
| (30) | Number | Date | Country code |
| 201361750437 P | 2013-01-09 | US | |
| 201361863452 P | 2013-08-08 | US | |
| 201361909421 P | 2013-11-27 | US |
| (72) |
WIEGAND, Stanley, J., US
LOBOV, Ivan, B., US
|
| (73) |
Regeneron Pharmaceuticals, Inc.,
777 Old Saw Mill River Road, Tarrytown, NY 10591,
US
|
| (54) | ANTI-PDGFR-BETA ANTIBODIES AND USES THEREOF |
| ANTI-PDGFR-BETA ANTIBODIES AND USES THEREOF |